Ancera Garners $1,277,500 New Funding

  • Feed Type
  • Date
    11/26/2013
  • Company Name
    Ancera
  • Mailing Address
    21 Business Park Drive Branford, CT 06405
  • Company Description
    The company is developing a rapid, portable technology platform for the separation, quantitative detection and identification of minute concentrations of various pathogens from whole blood or other bodily fluids. Ancera’s platform is based on technology it is licensing exclusively from Yale University. The technology uses magnetic fields to manipulate biologic cells via a ferromagnetic fluid.
  • Website
    http://www.anceradx.com
  • Transaction Type
    Debt
  • Transaction Amount
    $1,277,500
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.